VAERS reports by lot

Moderna COVID-19 lot 026L21B: VAERS reports

580 VAERS reports list lot 026L21B as a Moderna COVID-19 vaccine, received between 2022-02-21 and 2023-09-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
580
Reports
4%
Marked serious
2
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)12525%
Gastrointestinal6914%
Neurological5812%
Cardiac / Cardiovascular459%
Respiratory429%
Injection-site / Local reaction429%
Dermatological (non-injection-site)367%
Musculoskeletal275%
Allergic / Anaphylactic245%
Psychiatric / Neuropsychiatric122%
Thrombotic / Hematological51%
Reproductive / Menstrual51%
Autoimmune / Immune-mediated20%

Where reports came from

U.S. state of the reporter, where given (top 12).

Colorado190
Iowa64
Washington29
Missouri29
Virginia28
Michigan19
California15
Florida10
Texas10
New Hampshire10
New York9
Connecticut9

Reports by month received

2022-029
2022-0352
2022-04204
2022-05205
2022-067
2022-0737
2022-0835
2022-094
2022-102
2022-112
2022-123
2023-011
2023-023
2023-038
2023-047
2023-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.